"Research designates an activity designed to provide diagnosis, preventive treatment or therapy to particular individual"

A. Phase IV trials find more information about long-term benefits and side effects: Phase IV trials occur after a drug has received regulatory approval and is marketed to the public. Post-marketing studies assess long-term effectiveness, adverse effects, and overall safety in a broader population. They provide real-world data that may not have been evident in earlier phases.

B. Phase III trials test if a new treatment is better than a standard treatment: Phase III trials involve large participant groups and compare a new intervention to the current standard of care or placebo. These studies evaluate effectiveness, monitor adverse reactions, and collect sufficient evidence for regulatory approval.

C. Phase I trials test the safety, side effects, best dose, and timing of a new treatment: Phase I trials are the initial step in testing a new treatment in humans, typically involving a small number of participants. The primary focus is on safety, tolerability, pharmacokinetics, and determining appropriate dosage ranges. These studies establish foundational safety data before larger trials.

D. Phase II trials test the effectiveness of an experimental drug on a particular disease or condition as well as further assess the safety: Phase II trials involve a larger group of participants who have the target condition. These studies evaluate preliminary efficacy while continuing to monitor safety and optimal dosing.

A. Control group receive a standard (no treatment or placebo) treatment: RCTs include a control group that either receives no intervention, standard care, or a placebo. This allows researchers to compare the effects of the experimental intervention against a baseline and determine the true efficacy of the treatment while controlling for confounding variables.

B. Provide the most direct evidence of cause-and-effect relationships between treatment and outcome: RCTs are considered the gold standard for establishing causality because randomization reduces confounding and ensures that differences in outcomes can be attributed to the intervention rather than other factors.

C. Treatment groups are compared over time to see how the treatments affect the participant: RCTs involve longitudinal comparison between intervention and control groups, assessing changes in outcomes over time. This analysis helps determine the effectiveness and safety of treatments as participants are monitored for development of intended or adverse effects.

D. Participants are randomly assigned to groups to minimize biases: Random assignment ensures that each participant has an equal chance of being placed in any group, reducing selection bias and balancing known and unknown confounding variables across groups. This enhances the internal validity of the trial and the reliability of conclusions.